The Confidence Project by BOTOX® Cosmetic Unveils This Year's Grant Recipients Pharmaceutical Investing
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+ for Breast Cancer Biotech Investing
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027 Biotech Investing
LYVDELZI® RECEIVES HEALTH CANADA APPROVAL FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS Pharmaceutical Investing
CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO Pharmaceutical Investing
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference Life Science Investing
RINVOQ® Demonstrated Superiority Versus HUMIRA® for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor Pharmaceutical Investing
